Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06201988
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-12
First Post:
2023-12-29
Brief Title:
Revealing Engagement Patterns Among Hepatic Encephalopathy Patients
Sponsor:
Power Life Sciences Inc
Organization:
Power Life Sciences Inc
Study Overview
Official Title:
Assessing Patient Engagement and Understanding in Hepatic Encephalopathy Clinical Research
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate the influences behind patient choices regarding involvement discontinuation or re-engagement in hepatic encephalopathy clinical trials Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors
In essence this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials Elevating participation rates could expedite the development of innovative treatments for this challenging condition
In essence this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials Elevating participation rates could expedite the development of innovative treatments for this challenging condition
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None